Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04496076 · ClinicalTrials.gov registry record
COVID-19 Brain Injury
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 300
- Enrollment target
NCT04496076: Completed study, sponsored by University of Pittsburgh.
NCT04496076 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04496076 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
A prospective cohort minimal risk study to determine the impact of the COVID-19 crisis on outcomes of neurologically injured ICU patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-04-02 |
| Est. Completion | 2021-05-31 |
What the finished NCT04496076 record still lists
NCT04496076 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04496076 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04496076 about?
NCT04496076 is a clinical study titled "COVID-19 Brain Injury". A prospective cohort minimal risk study to determine the impact of the COVID-19 crisis on outcomes of neurologically injured ICU patients.
What is the current status of trial NCT04496076?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2020-04-02. Estimated completion is 2021-05-31.
Who is sponsoring clinical trial NCT04496076?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI